Thumb Osteoarthritis Treatment

The thumb osteoarthritis treatment is aimed at preventing further degradation of articular cartilage. Osteoarthritis is a degenerative disease that affects joints. All body joints including the thumb are affected. For thumb osteoarthritis, women are more common than men. Normally, thumb osteoarthritis develops after age 40. Thumb osteoarthritis mainly affects the base of the thumb, the fleshy part of the thumb, and the joint near the wrist. However, the trapezoidal metacarpal joint joint at the base of the thumb (also known as the first carpometacarpal joint articulation) is the most common joint that is prone to degeneration.

Osteoarthritis results and goals The purpose of this paper is to provide literature review of osteoarthritis. The topics covered are as follows. What is osteoarthritis in fact, its cause, symptom, treatment, therapy, side effects of this therapy and other treatments. This SSA has two goals. - Karl Sagan (1934-1996), a famous American astronomer born in 1983, firstly defined and explained the nuclear winter phenomenon. In a nuclear winter article based on the academic paper "Nuclear War on the Global Atmosphere", Sagan explained and analyzed unintended consequences, a sharp decline in world temperature, nuclear war.

Two Reviews of Small Scale Randomized Control Study of Methylsulfonylmethane in Reducing Knee Arthralgia in Osteoarthritis (OA) There were 168 participants in two trials, 52 of whom received MSM, 1.5 g / Day or 6.0 g / day. Authors of the reviewers say "There is no clear conclusion yet" and "There is no clear evidence that MSM is superior to placebo in the treatment of mild to moderate osteoarthritis."

Small research on potential MSM treatment has been done for animals and humans. These MSM trials provide some advantages, especially for the treatment of oxidative stress and osteoarthritis, but there is no evidence of other uses. The comprehensive database of Natural Medicines contains an up-to-date list of health related MSM studies. In clinical trials, there are studies in which little or no side effects have been reported after 12 weeks of dosing. The side effects reported in these studies included mild gastrointestinal disorders, fatigue, headache, but did not appear to be different from placebo. In the study of large joint osteoarthritis in the last 26 weeks, no abnormal changes in adverse events or laboratory monitoring were observed when taking 6 grams of MSM a day. MSM is considered "probably safe" at the therapeutic dose, but further research is needed to evaluate the safety of long-term use.